Beta-casein A2 and reducing or preventing symptoms of lactose intolerance

A method of preventing or reducing the symptoms of lactose intolerance in an animal comprises the consumption by the animal of a composition containing beta-casein, or providing the composition to theanimal for consumption, where the beta-casein comprises at least 75% by weight beta-casein A2. The e...

Full description

Saved in:
Bibliographic Details
Main Authors CLARKE ANDREW JOHN, TRIVEDI MALAV SUCHIN
Format Patent
LanguageChinese
English
Published 18.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A method of preventing or reducing the symptoms of lactose intolerance in an animal comprises the consumption by the animal of a composition containing beta-casein, or providing the composition to theanimal for consumption, where the beta-casein comprises at least 75% by weight beta-casein A2. The effect is both acute (post-exposure to the composition) and ongoing (future exposure to lactose). 用于预防或减轻动物的乳糖不耐受症状的方法,包括使动物消耗包含β-酪蛋白的组合物或给动物提供用于消耗的该组合物,其中β-酪蛋白包含至少75%重量的β-酪蛋白A2。这种作用是急性的(暴露于组合物后)和进行性的(即将暴露于乳糖)。
AbstractList A method of preventing or reducing the symptoms of lactose intolerance in an animal comprises the consumption by the animal of a composition containing beta-casein, or providing the composition to theanimal for consumption, where the beta-casein comprises at least 75% by weight beta-casein A2. The effect is both acute (post-exposure to the composition) and ongoing (future exposure to lactose). 用于预防或减轻动物的乳糖不耐受症状的方法,包括使动物消耗包含β-酪蛋白的组合物或给动物提供用于消耗的该组合物,其中β-酪蛋白包含至少75%重量的β-酪蛋白A2。这种作用是急性的(暴露于组合物后)和进行性的(即将暴露于乳糖)。
Author CLARKE ANDREW JOHN
TRIVEDI MALAV SUCHIN
Author_xml – fullname: CLARKE ANDREW JOHN
– fullname: TRIVEDI MALAV SUCHIN
BookMark eNqNir0KwkAQBq_Qwr93WB8gkJjGNgZFGyv7sFy-yEGye9yegm-vgg8gDAwDs3QzUcHCXQ7IXHg2BKFmRyw9JfQPH-ROmigmPCH5W_aaYtbJSAca2Wc1UJCsIxKLx9rNBx4Nm59Xbns63tpzgagdLLKHIHfttarKffmhbup_njfBsDYO
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate β-酪蛋白A2和减轻或预防乳糖不耐受症状
ExternalDocumentID CN110800803A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN110800803A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:50:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN110800803A3
Notes Application Number: CN201911100359
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200218&DB=EPODOC&CC=CN&NR=110800803A
ParticipantIDs epo_espacenet_CN110800803A
PublicationCentury 2000
PublicationDate 20200218
PublicationDateYYYYMMDD 2020-02-18
PublicationDate_xml – month: 02
  year: 2020
  text: 20200218
  day: 18
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies A2 MILK COMPANY LTD
RelatedCompanies_xml – name: A2 MILK COMPANY LTD
Score 3.3744397
Snippet A method of preventing or reducing the symptoms of lactose intolerance in an animal comprises the consumption by the animal of a composition containing...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEWING GUM
COCOA
COCOA PRODUCTS, e.g. CHOCOLATE
CONFECTIONERY
DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE
FODDER
FOODS OR FOODSTUFFS
HUMAN NECESSITIES
ICE-CREAM
MAKING THEREOF
MILK OR CHEESE SUBSTITUTES
PREPARATION THEREOF
SUBSTITUTES FOR COCOA OR COCOA PRODUCTS
THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Title Beta-casein A2 and reducing or preventing symptoms of lactose intolerance
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200218&DB=EPODOC&locale=&CC=CN&NR=110800803A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVdH6YAXJLZjmYbKHIO2mpQpNi1TpreSxwUi7CU1E9Nc7G1LrRW_7gGEY-HZmd7-ZAbgxMKxN4lBXNSewVZNyrlIaWWqsBzJA1TuJJROcR_7d8Nl8nFmzBrytc2GqOqEfVXFERFSEeC-r8zrfPGJ5FbeyuA1TXMruB1PXU-rbccU4cBSv5_YnY2_MFMZc5iv-kyvZ7jI6MrpbsI1htC3R0H_pyayU_LdLGRzAzgSlifIQGl-vLdhj685rLdgd1R_eOKyxVxzBQw81UiP0OqkgXZ0EIiYrWXgVnQ_JViSvizHhrPhc5mW2LEiWkIVsqFNwkooyW3DZRoMfw_WgP2VDFXWa_xhgzvyN-sYJNEUm-CkQnYYB5VrSMcLIdGKbxkFoJpqdmFpAI-qcQftvOe3_Ns9hXxpTspM7zgU0y9U7v0TnW4ZXldW-AaxjiTo
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq6L1tYLkFkzzMNlDkHbT0mqbFqnSW8ljg5U2CU1E9Nc7G1LrRW_7gGEY-HZmd7-ZAbjRMKyNQl-VFcszZZ1yLlMaGHKoeiJAVZuRIRKch-5d71l_mBrTCrytc2GKOqEfRXFERFSAeM-L8zrdPGI5Bbcyu_XnuJTcdye2I5W344JxYElO2-6MR86ISYzZzJXcJ1uw3UV0pLW2YBtDbFOgofPSFlkp6W-X0t2HnTFKi_MDqHy91qHG1p3X6rA7LD-8cVhiLzuEfhs1kgP0OvOYtFTixSFZicKr6HxIsiJpWYwJZ9nnMs2TZUaSiCxEQ52Mk3mcJwsu2mjwI7judiasJ6NOsx8DzJi7UV87hmqcxPwEiEp9j3Ilamp-oFuhSUPP1yPFjHTFowG1TqHxt5zGf5tXUOtNhoPZoO8-nsGeMKxgKjetc6jmq3d-gY449y8LC34DSASMLQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Beta-casein+A2+and+reducing+or+preventing+symptoms+of+lactose+intolerance&rft.inventor=CLARKE+ANDREW+JOHN&rft.inventor=TRIVEDI+MALAV+SUCHIN&rft.date=2020-02-18&rft.externalDBID=A&rft.externalDocID=CN110800803A